Olivier Heinzlef
Overview
Explore the profile of Olivier Heinzlef including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thouvenot E, Laplaud D, Lebrun-Frenay C, Derache N, Le Page E, Maillart E, et al.
JAMA
. 2025 Mar;
PMID: 40063041
Importance: Vitamin D deficiency is a risk factor for multiple sclerosis (MS) and is associated with the risk of disease activity, but data on the benefits of supplementation are conflicting....
2.
De Seze J, Labauge P, Liblau R, Martinez M, Moreau T, Suchet L, et al.
Adv Ther
. 2025 Feb;
PMID: 39969782
Introduction: Dimethyl fumarate (DMF) has demonstrated a favorable benefit-risk profile in patients with relapsing-remitting multiple sclerosis (RRMS). Some patients may develop lymphopenia on DMF; therefore, LymphoTEC evaluated absolute lymphocyte count...
3.
Lefort M, Dejardin O, Berger E, Camdessanche J, Ciron J, Clavelou P, et al.
Mult Scler
. 2024 Dec;
31(1):69-80.
PMID: 39618051
Background: We hypothesized that differences in access to disease-modifying treatments (DMTs) could explain the association between socioeconomic status and disability progression in multiple sclerosis (MS). Objective: This study aimed to...
4.
Lefort M, Dejardin O, Berger E, Camdessanche J, Ciron J, Clavelou P, et al.
Mult Scler
. 2024 Nov;
31(1):59-68.
PMID: 39614776
Background: Studies have reported an association between socioeconomic status and disability progression in multiple sclerosis (MS), but findings using the pre-MS individual socioeconomic status are missing. Objective: The objective was...
5.
Labauge P, Creange A, Moreau T, Nouvet-Gire J, Pedespan B, Heinzlef O, et al.
Neurol Ther
. 2024 Nov;
14(1):177-192.
PMID: 39527163
Introduction: Treatment persistence and adherence are essential for achieving therapeutic goals in patients with multiple sclerosis (MS). OroSEP is an independent patient-support program (PSP) in France for patients with relapsing-remitting...
6.
Hay M, Rollot F, Casey R, Kerbrat A, Edan G, Mathey G, et al.
Neurology
. 2024 Sep;
103(8):e209886.
PMID: 39321406
Background And Objectives: Although rituximab failed to demonstrate a significant effect on disability progression in primary progressive multiple sclerosis (PPMS), ocrelizumab succeeded. Our main objective was to analyze confirmed disability...
7.
Gavoille A, Rollot F, Casey R, Kerbrat A, Le Page E, Bigaut K, et al.
JAMA Neurol
. 2024 Jul;
81(8):814-823.
PMID: 38949816
Importance: Understanding the association between clinically defined relapses and radiological activity in multiple sclerosis (MS) is essential for patient treatment and therapeutic development. Objective: To investigate clinical events identified as...
8.
Jouvenot G, Courbon G, Lefort M, Rollot F, Casey R, Le Page E, et al.
JAMA Neurol
. 2024 Mar;
81(5):490-498.
PMID: 38526462
Importance: A recent randomized clinical trial concluded that discontinuing medium-efficacy therapy might be a reasonable option for older patients with nonactive multiple sclerosis (MS), but there is a lack of...
9.
Benallegue N, Rollot F, Wiertlewski S, Casey R, Debouverie M, Kerbrat A, et al.
JAMA Neurol
. 2024 Feb;
81(3):273-282.
PMID: 38345791
Importance: Moderately effective therapies (METs) have been the main treatment in pediatric-onset multiple sclerosis (POMS) for years. Despite the expanding use of highly effective therapies (HETs), treatment strategies for POMS...
10.
Federau C, Hainc N, Edjlali M, Zhu G, Mastilovic M, Nierobisch N, et al.
Neuroradiology
. 2024 Jan;
66(3):361-369.
PMID: 38265684
Purpose: The assessment of multiple sclerosis (MS) lesions on follow-up magnetic resonance imaging (MRI) is tedious, time-consuming, and error-prone. Automation of low-level tasks could enhance the radiologist in this work....